علاج التهاب الأنف التحسسي مع الأعراض المستمرة المؤثرة على جودة الحياة

References

• Frequency can be divided into intermittent or persistent (more than four days per week and more than four weeks per year, respectively).
• The International Primary Care Respiratory Group; British Society for Allergy and Clinical Immunology; and American Academy of Allergy, Asthma, and Immunology recommend intranasal corticosteroids alone for the initial treatment of persistent symptoms affecting quality of life and second-generation nonsedating antihistamines for mild intermittent disease.
• Allergen avoidance and patient education are part of initial management.
• An intranasal corticosteroid alone should be the initial treatment for allergic rhinitis with symptoms affecting quality of life.
• Intranasal corticosteroids are the mainstay of treatment for allergic rhinitis.
• Their onset of action can be less than 30 minutes, although peak effect may take several hours to days, with maximum effectiveness usually noted after two to four weeks of use.